<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Bridgewater Surgeries</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where Bridgewater Surgeries is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1303000Q0&amp;denomIds=13.3&amp;selectedTab=summary">Lidocaine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Topical local anaesthetics and antipruritics</td>
      <td>33</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>41.22</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1303000Q0AAAAAA&amp;denomIds=13.3&amp;selectedTab=summary" target="_blank">Lidocaine 0.5% gel : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1307000C0&amp;denomIds=13.7&amp;selectedTab=summary">Formaldehyde</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Preparations for warts and calluses</td>
      <td>27</td>
      <td>0.11</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>11.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1307000C0AAACAC&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Formaldehyde solution : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1307000C0AAALAL&amp;denomIds=13.7&amp;selectedTab=summary" target="_blank">Formaldehyde (Buffered) 4% solution : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0503010AM&amp;denomIds=5.3.1&amp;selectedTab=summary">Emtricitabine and tenofovir alafenamide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>HIV infection</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.02</td>
      <td>0.11</td>
      <td>9.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0503010AMAAAAAA&amp;denomIds=5.3.1&amp;selectedTab=summary" target="_blank">Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0106010H0&amp;denomIds=1.6.1&amp;selectedTab=summary">Methylcellulose</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Bulk-forming laxatives</td>
      <td>142</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>9.02</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0106010H0AAACAC&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Methylcellulose 500mg tablets : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0407020K0&amp;denomIds=4.7.2&amp;selectedTab=summary">Diamorphine hydrochloride (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>38</td>
      <td>Opioid analgesics</td>
      <td>2389</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0407020K0AAAFAF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Diamorphine 100mg powder for solution for injection ampoules : 33</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0407020K0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Diamorphine 10mg powder for solution for injection ampoules : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0407020K0AAAAAA&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Diamorphine 5mg powder for solution for injection ampoules : 3</a></div></td></tr></tbody></table>

        <h2>Prescribing where Bridgewater Surgeries is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=1311040K0&amp;denomIds=13.11.4&amp;selectedTab=summary">Iodine compounds</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Chlorine and iodine</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.97</td>
      <td>0.15</td>
      <td>-6.51</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0704030G0&amp;denomIds=7.4.3&amp;selectedTab=summary">Potassium citrate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Drugs used in urological pain</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.93</td>
      <td>0.24</td>
      <td>-3.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0&amp;denomIds=1.1.2&amp;selectedTab=summary">Alginic acid compound preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>695</td>
      <td>Compound Alginates and proprietary indigestion preparations</td>
      <td>718</td>
      <td>0.97</td>
      <td>1.00</td>
      <td>0.01</td>
      <td>-2.12</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0AAAHAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Alginate raft-forming oral suspension sugar free : 35</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0AAALAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg/5ml susp SF : 38</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEADAJ&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Infant oral powder sachets : 107</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEAFAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint Liquid Relief : 36</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEAIAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral suspension aniseed (Reckitt Benckiser) : 54</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEAQAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance Mint chewable tablets (Reckitt Benckiser) : 47</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEBEAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Advance oral susp peppermint (Reckitt Benckiser) : 294</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEAWAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Strawberry chewable tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEACAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Original Aniseed Relief : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEASA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action Liquid peppermint : 18</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEAUAR&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Peppermint chewable tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BIABAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid peppermint : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BQACAL&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Acidex Advance oral suspension aniseed : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BEARA0&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Gaviscon Double Action chewable tablets mint : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0BIAAAH&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Peptac liquid aniseed : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0101021B0AAAPAP&amp;denomIds=1.1.2&amp;selectedTab=summary" target="_blank">Sodium algin 500mg/Potassium bicarb 100mg chew tab SF : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000&amp;denomIds=13.2.1&amp;selectedTab=summary">Other emollient preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>640</td>
      <td>Emollients</td>
      <td>852</td>
      <td>0.75</td>
      <td>0.89</td>
      <td>0.07</td>
      <td>-1.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBICBW&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 500 lotion : 414</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBJGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase gel : 54</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBKFA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol cream : 47</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBAHAV&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Ultrabase cream : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000AACMCM&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Propylene glycol 20% in Aqueous cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBKDA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno Skin Relief moisturising lotion with shea butter : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBLACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase Dayleve gel : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBJPCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum cream : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBJMCB&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno lotion : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBBAAL&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 cream : 18</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBAEA3&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Diprobase ointment : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000AAA3A3&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 95% / Liquid paraffin 5% ointment : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBAUA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 lotion : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBCJA8&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno cream : 20</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000AAA6A6&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 50% / Liquid paraffin 50% ointment : 24</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=130201000BBKKCD&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Oilatum Junior cream : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>24</td>
      <td>Theophylline</td>
      <td>69</td>
      <td>0.35</td>
      <td>0.83</td>
      <td>0.25</td>
      <td>-1.97</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0301030S0BKAAAR&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 400mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0301030S0BKACAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 300mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=E82013&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 10</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>